Study Title
Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19
Purpose
Provide access to COVID-19 convalescent plasma
Eligibility
Study Process
Trial Details
Investigator:
Joseph Bocchini, M.D.
IRB:
Willis-Knighton
IRB Number:
Trial Type:
NA
Sponsor:
Mayo Clinic
Contact Information: